Monday, December 31, 2012 12:14:08 PM
Yes, the SLRC 6.75% senior notes (Symbol SLRA) are higher on the SLRC capital structure, but if an investor is confident in the SLRC management team why not take the much higher dividend yield of the common over the interest yield on the notes. We buy BDC's for the high dividend yields coupled with the expectation of capital gains from an increase in price of the stock. Just my opinion.
To all:
On an unrelated subject, I put some words on TCPC over on the Yahoo board if anyone wants to go over there and take a look.
Also I looked at the four new BDC's that recently came public in the last three months and considering size, investment advisor, underwriting team, initial dividend declaration, pro forma price to book, etc., I found WhiteHorse Finance (WHF) to be most interesting. And this morning, five analysts came out with initial coverage on the stock. They were all "buys" and the target prices averaged $15.90. (stock is at $14.75). If anyone is interested I can tab the ratings of each analyst and each target price.
Happy New Year.
Jan
Recent SLRC News
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Form 40-17G - Fidelity Bond [Rule 17G-1(g)] • Edgar (US Regulatory) • 03/08/2024 05:30:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:53:22 PM
- SLR Investment Corp. Announces Quarter and Year Ended December 31, 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 09:01:00 PM
- SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System • GlobeNewswire Inc. • 02/01/2024 02:00:00 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2023 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:04:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:20:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:12:10 PM
- SLR Investment Corp. Announces Quarter Ended September 30, 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 09:03:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:03:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 08:01:27 PM
- SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 09/29/2023 12:00:00 PM
- SLR Welcomes Chris York as a Partner • PR Newswire (US) • 09/18/2023 08:03:00 PM
- SLR Appoints Brad Coleman as an Operating Partner • PR Newswire (US) • 09/18/2023 08:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 03:00:12 PM
- SLR Investment Corp. Announces Monthly Distribution for September 2023 • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:31:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 08:15:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 08:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:30:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:07:38 PM
- SLR Investment Corp. Announces Quarter Ended June 30, 2023 Financial Results • GlobeNewswire Inc. • 08/08/2023 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 03:00:10 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM